Immunology and Biotherapies
40.0K views | +0 today
Follow
Immunology and Biotherapies
Page Ressources et Actualités du DIU immunologie et biothérapies
Your new post is loading...
Your new post is loading...
Scooped by Gilbert C FAURE
July 26, 2012 3:23 PM
Scoop.it!

9th Stem Cell Research & Therapeutics Conference

Biomarker, Oncology, cancer, Preclinical, Clinical, Companion Diagnostics, Epigenetics, translational medicine, Immunotherapies, Oncogenes, microarray, plasma proteins, tumor secretome...
No comment yet.
Scooped by Gilbert C FAURE
July 26, 2012 2:51 PM
Scoop.it!

Precision StemCell's Revolutionary InVivo Adult Stem Cell Reprogramming ... - MarketWatch (press release)

Precision StemCell's Revolutionary InVivo Adult Stem Cell Reprogramming ...MarketWatch (press release)Located in Gulf Shores, Alabama, Precision StemCell conducts stem cell procedures using advanced imaging techniques, which include an Open 3T MRI,...
No comment yet.
Scooped by Gilbert C FAURE
July 26, 2012 11:33 AM
Scoop.it!

Symposier - CD47 Antibody treatment shrinks or eliminates human cancer tumors in mice

Symposier - CD47 Antibody treatment shrinks or eliminates human cancer tumors in mice | Immunology and Biotherapies | Scoop.it
Uploaded and shared in Youtube by: institutesofmedicine — Nearly all cancers have been found to have a lot of a molecule called CD47, which tells the immune system "don't eat me." Blocking the CD47 signal has been show to let immune cells called...
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 3:13 PM
Scoop.it!

The Advantages of Placenta Banking - Relationship Articles Daily

The Advantages of Placenta Banking - Relationship Articles Daily | Immunology and Biotherapies | Scoop.it
Preserving stem cells from your baby's umbilical cord blood is a significant investment, and preserving the much larger amount of stem cells that are (The Advantages of Placenta Banking: Preserving stem cells from your baby's umbilical cord blood ...
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 1:52 PM
Scoop.it!

Antibody-Drug Conjugates: Guided Missiles Deployed Against Cancerous Cells

Antibody-Drug Conjugates: Guided Missiles Deployed Against Cancerous Cells | Immunology and Biotherapies | Scoop.it
Antibodies directed against tumor cell antigens or overexpressed proteins are currently the fastest-growing class of targeted cancer therapeutics.
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 11:13 AM
Scoop.it!

Serum IgG responses against Asp... [Biol Blood Marrow Transplant. 2012] - PubMed - NCBI

PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 9:00 AM
Scoop.it!

Oncology News - Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis |4144529

Oncology Medical Article: Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis (Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus...)...
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 4:55 AM
Scoop.it!

Effect of a monoclonal antibody to PCSK9, REGN727/SAR... [Lancet. 2012] - PubMed - NCBI

PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 3:49 AM
Scoop.it!

New guidelines urge immediate treatment after HIV infection - Harvard Health Publications

New guidelines urge immediate treatment after HIV infection - Harvard Health Publications | Immunology and Biotherapies | Scoop.it
New guidelines now urge adults who have been infected with HIV to start taking HIV-fighting drugs as soon as possible, ideally within two weeks of being diagnosed with the infection, rather than waiting to see what happens with white blood cell...
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 3:48 AM
Scoop.it!

Pluristem Focuses On Therapeutic Cells Delivered Intramuscularly ...

20000000. This is the number of peripheral artery disease patients Pluristem Therapeutics, a placenta-based cell therapy company, is working to assist. The company recently released information regarding the effectiveness of cell therapy ...
No comment yet.
Scooped by Gilbert C FAURE
July 24, 2012 1:23 PM
Scoop.it!

Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme - Full Text View - ClinicalTrials.gov

Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recur http://t.co/KEVBD7kb...
No comment yet.
Scooped by Gilbert C FAURE
July 24, 2012 11:28 AM
Scoop.it!

Free Article: Intraspinal Stem Cell Transplantation - Blogs

Free Article: Intraspinal Stem Cell Transplantation - Blogs | Immunology and Biotherapies | Scoop.it
Free Article: Intraspinal Stem Cell Transplantation. leave a comment ». Background: No United States-based clinical trials have attempted delivery of biological therapies directly to the spinal cord for treatment of amyotrophic ...
No comment yet.
Scooped by Gilbert C FAURE
July 24, 2012 7:14 AM
Scoop.it!

DGAP-News: SuppreMol GmbH: SuppreMol begins development of Anti-IL-3 monoclonal antibody to diagnose and treat early stage Rheumatoid Arthritis

DGAP-News: SuppreMol GmbH / Key word(s): StudySuppreMol GmbH: SuppreMol begins development of Anti-IL-3 monoclonalantibody to diagnose and treat early stage Rheumatoid Arthritis24.07.2012 /...
No comment yet.
Scooped by Gilbert C FAURE
July 26, 2012 2:52 PM
Scoop.it!

Pluristem, NIH to study stem cells to treat radiation syndrome - Reuters

Pluristem, NIH to study stem cells to treat radiation syndromeReutersTEL AVIV, July 26 (Reuters) - Israel-based Pluristem Therapeutics Inc has received an invitation from the U.S.
No comment yet.
Scooped by Gilbert C FAURE
July 26, 2012 2:51 PM
Scoop.it!

ACT Issued Broad Patent for Human RPE Cells Derived From All Types of ... - MarketWatch (press release)

ACT Issued Broad Patent for Human RPE Cells Derived From All Types of ...MarketWatch (press release)MARLBOROUGH, Mass., Jul 26, 2012 (BUSINESS WIRE) -- Advanced Cell Technology, Inc.
No comment yet.
Scooped by Gilbert C FAURE
July 26, 2012 11:30 AM
Scoop.it!

Neuralstem Receives Notice Of Issuance For Patent Covering Human Neural Cell Transplantation For Neurodegenerative Conditions

Neuralstem Receives Notice Of Issuance For Patent Covering Human Neural Cell Transplantation For Neurodegenerative Conditions | Immunology and Biotherapies | Scoop.it
ROCKVILLE, Md., July 26, 2012 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that it received a...
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 1:54 PM
Scoop.it!

World’s first biosimilar antibody* is approved in Korea

World’s first biosimilar antibody* is approved in Korea | Immunology and Biotherapies | Scoop.it
South Korean biosimilar manufacturer Celltrion, today declared that, Korean Food and Drug Administration approved its first biosimilar monoclonal antibody, Remsima. (World's 1st biosimilar monoclonal antibody REMSIMA approved!
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 11:14 AM
Scoop.it!

De Novo DQ Donor-Specific Antibodies Are Associated With a Significant Risk of Antibody-Mediated Rejection and Transplant Glomerulopathy | Antibody Chain

De Novo DQ Donor-Specific Antibodies Are Associated With a Significant Risk of Antibody-Mediated Rejection and Transplant Glomerulopathy | Antibody Chain | Immunology and Biotherapies | Scoop.it
The importance of human leukocyte antigen (HLA) matching in renal transplantation is well recognized, with HLA-DR compatibility having the greatest influence.
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 9:05 AM
Scoop.it!

Sweat glands grown from newly identified stem cells

Sweat glands grown from newly identified stem cells | Immunology and Biotherapies | Scoop.it
To date, few fundamentals have been known about the most common gland in the body, the sweat glands that are essential to controlling body temperature, allowing humans to live in the world’s diverse climates.
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 8:59 AM
Scoop.it!

Symposier - Nimotuzumab: Proposed Mechanism of Action

Symposier - Nimotuzumab: Proposed Mechanism of Action | Immunology and Biotherapies | Scoop.it
Uploaded and shared in Youtube by: ymbiosciences —Nimotuzumab is a humanized monoclonal antibody that targets and binds to the epidermal growth factor receptor (EGFR).
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 4:54 AM
Scoop.it!

World’s leading transplantation experts lock in Melbourne for 2015 | Invest Victoria Blog

World’s leading transplantation experts lock in Melbourne for 2015 | Invest Victoria Blog | Immunology and Biotherapies | Scoop.it
World’s leading transplantation experts lock in #Melbourne for 2015 http://t.co/rbxT9b3W...
No comment yet.
Scooped by Gilbert C FAURE
July 25, 2012 3:49 AM
Scoop.it!

Researchers discover new target for vaccine development in abundant immune ... - Medical Xpress

Researchers discover new target for vaccine development in abundant immune ... - Medical Xpress | Immunology and Biotherapies | Scoop.it
Researchers discover new target for vaccine development in abundant immune ...Medical XpressResearchers evaluated healthy human tissues key to the immune system to assess the abundance of neutrophils in the lymph nodes, tonsils, lymphoid tissue in...
No comment yet.
Scooped by Gilbert C FAURE
July 24, 2012 1:24 PM
Scoop.it!

Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia - Full Text View - ClinicalTrials.gov

Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagno...
No comment yet.
Rescooped by Gilbert C FAURE from Immune-Monitoring
July 24, 2012 1:21 PM
Scoop.it!

Tumor progression-related transmembrane protein aspartate-{Beta}-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.

antigenic target


Via Marcelo de Carvalho Bittencourt
No comment yet.
Scooped by Gilbert C FAURE
July 24, 2012 7:15 AM
Scoop.it!

Aegis Awarded Patent for Monoclonal Antibody Formulations That Avoid Oxidative Damage Due to Polysorbate Surfactants

SAN DIEGO, CA -- (Marketwire) -- 07/24/12 -- Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,226,949 providing broad protection for stabilized formulations of monoclonal antibodies.
No comment yet.